LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular (Nasdaq: LMAT) announced its participation in three investor conferences throughout September 2020. JJ Pellegrino, CFO, will engage in the Barrington Research Virtual Fall Investment Conference on September 9, followed by a presentation at the Cantor Virtual Global Healthcare Conference on September 15 at 4:00 PM EDT. Pellegrino will also present at the Sidoti Virtual Investor Conference on September 23 at 10:45 AM EDT. LeMaitre specializes in devices for treating peripheral vascular disease, impacting over 200 million globally.
- None.
- None.
BURLINGTON, Mass., Aug. 31, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in three investor conferences in September.
JJ Pellegrino, Chief Financial Officer, is scheduled to participate in the 13th Annual Barrington Research Virtual Fall Investment Conference on Wednesday, September 9, 2020.
David Roberts, President, is scheduled to present at Cantor Virtual Global Healthcare Conference on Tuesday, September 15, 2020, at 4:00 PM EDT.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Sidoti Virtual Investor Conference on Wednesday, September 23, 2020, at 10:45 AM EDT.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Sandra Millar +1-781-425-1686
FAQ
What investor conferences is LeMaitre Vascular participating in September 2020?
Who is presenting for LeMaitre Vascular at the investor conferences?
What is the focus of LeMaitre Vascular's products?
When is LeMaitre Vascular's presentation at the Cantor Virtual Global Healthcare Conference?